A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets

被引:5
|
作者
Blanco, Ester [1 ]
Ibanez-Vea, Maria [1 ,2 ]
Hernandez, Carlos [1 ]
Drici, Lylia [3 ]
Martinez de Morentin, Xabier [4 ]
Gato, Maria [1 ]
Ausin, Karina [5 ]
Bocanegra, Ana [1 ]
Zuazo, Miren [1 ]
Chocarro, Luisa [1 ]
Arasanz, Hugo [1 ]
Fernandez-Hinojal, Gonzalo [1 ]
Fernandez-Irigoyen, Joaquin [5 ]
Smerdou, Cristian [6 ,7 ]
Garnica, Maider [1 ]
Echaide, Miriam [1 ]
Fernandez, Leticia [1 ]
Morente, Pilar [1 ]
Ramos-Castellanos, Pablo [1 ]
Llopiz, Diana [8 ,9 ,10 ]
Santamaria, Enrique [5 ]
Larsen, Martin R. [11 ]
Escors, David [1 ]
Kochan, Grazyna [1 ]
机构
[1] Fdn Miguel Servet Complejo Hospitalario Navarra U, Oncoimmunol Grp, Navarrabiomed, Pamplona 31008, Spain
[2] Univ Publ Navarra, Inst Multidisciplinary Res Appl Biol IMAB UPNA, Genet Genom & Microbiol Res Grp, Campus Arrosadia, Pamplona 31006, Spain
[3] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
[4] Navarra Inst Hlth Res IdiSNA, Inst Hlth Carlos III ISCIII, Bioinformat Grp, Navarrabiomed Biomed Res Ctr, Irunlarrea 3, Pamplona 31008, Spain
[5] Univ Publ Navarra UPNA, Complejo Hospitalario Navarra CHN, Proteored ISCIII, Prote Platform,Navarrabiomed,IdISNA, Irunlarrea 3, Pamplona 31008, Spain
[6] Cima Univ Navarra, Div Gene Therapy & Regulat Gene Express, Pamplona 31008, Spain
[7] Inst Invest Sanitaria Navarra IdISNA, Pamplona 31008, Spain
[8] Univ Navarra, Ctr Invest Med Aplicada CIMA, Pamplona 31008, Spain
[9] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona 31008, Spain
[10] Inst Invest Sanitaria Navarra, IdiSNA, Pamplona 31008, Spain
[11] Univ Southern Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark
来源
JOURNAL OF PERSONALIZED MEDICINE | 2021年 / 11卷 / 06期
基金
欧盟地平线“2020”;
关键词
myeloid-derived suppressor cells; cancer; tumor-infiltrating macrophages; SUPPRESSOR-CELLS; DIFFERENTIATION; MACROPHAGES; ACCUMULATION; CATHEPSINS; ACTIVATION; PROTEINS; TARGETS; MOUSE;
D O I
10.3390/jpm11060542
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Monocytic and granulocytic myeloid-derived suppressor cells together with tumor-infiltrating macrophages constitute the main tumor-infiltrating immunosuppressive myeloid populations. Due to the phenotypic resemblance to conventional myeloid cells, their identification and purification from within the tumors is technically difficult and makes their study a challenge. We differentiated myeloid cells modeling the three main tumor-infiltrating types together with uncommitted macrophages, using ex vivo differentiation methods resembling the tumor microenvironment. The phenotype and proteome of these cells was compared to identify linage-dependent relationships and cancer-specific interactome expression modules. The relationships between monocytic MDSCs and TAMs, monocytic MDSCs and granulocytic MDSCs, and hierarchical relationships of expression networks and transcription factors due to lineage and cancer polarization were mapped. Highly purified immunosuppressive myeloid cell populations that model tumor-infiltrating counterparts were systematically analyzed by quantitative proteomics. Full functional interactome maps have been generated to characterize at high resolution the relationships between the three main myeloid tumor-infiltrating cell types. Our data highlights the biological processes related to each cell type, and uncover novel shared and differential molecular targets. Moreover, the high numbers and fidelity of ex vivo-generated subsets to their natural tumor-shaped counterparts enable their use for validation of new treatments in high-throughput experiments.
引用
收藏
页数:21
相关论文
共 38 条
  • [1] Aberrant PGE2 metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells
    Eruslanov, Evgeniy
    Daurkin, Irina
    Vieweg, Johannes
    Daaka, Yehia
    Kusmartsev, Sergei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (07) : 848 - 855
  • [2] Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma
    Pinton, Laura
    Solito, Samantha
    Masetto, Elena
    Vettore, Marina
    Cane, Stefania
    Della Puppa, Alessandro
    Mandruzzato, Susanna
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [3] Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer
    Eruslanov, Evgeniy
    Neuberger, Molly
    Daurkin, Irina
    Perrin, George Q.
    Algood, Chester
    Dahm, Philipp
    Rosser, Charles
    Vieweg, Johannes
    Gilbert, Scott M.
    Kusmartsev, Sergei
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (05) : 1109 - 1119
  • [4] Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
    Toghraie, Fatemeh Sadat
    Bayat, Maryam
    Hosseini, Mahsa Sadat
    Ramezani, Amin
    CELLULAR ONCOLOGY, 2025, : 559 - 590
  • [5] Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade
    Alexander, Eric T.
    Mariner, Kelsey
    Donnelly, Julia
    Phanstiel, Otto
    Gilmour, Susan K.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2012 - 2022
  • [6] The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression
    Pan, Wen
    Zhu, Shu
    Qu, Kun
    Meeth, Katrina
    Cheng, Jijun
    He, Kaixin
    Ma, Hongdi
    Liao, Yan
    Wen, Xizhi
    Roden, Christine
    Tobiasova, Zuzana
    Wei, Zheng
    Zhao, Jun
    Liu, Jun
    Zheng, Ji
    Guo, Bo
    Khan, Sajid A.
    Bosenberg, Marcus
    Flavell, Richard A.
    Lu, Jun
    IMMUNITY, 2017, 47 (02) : 284 - +
  • [7] Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
    Krueger, Timothy E.
    Thorek, Daniel L. J.
    Meeker, Alan K.
    Isaacs, John T.
    Brennen, W. Nathaniel
    PROSTATE, 2019, 79 (03) : 320 - 330
  • [8] Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
    Lorenzo-Sanz, Laura
    Munoz, Purificacion
    CANCER MICROENVIRONMENT, 2019, 12 (2-3) : 119 - 132
  • [9] miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer
    Muehlberg, Leonie
    Kuehnemuth, Benjamin
    Costello, Eithne
    Shaw, Victoria
    Sipos, Bence
    Huber, Magdalena
    Griesmann, Heidi
    Krug, Sebastian
    Schober, Marvin
    Gress, Thomas M.
    Michl, Patrick
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [10] Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells
    Maisonneuve, Charles
    Tsang, Derek K. L.
    Foerster, Elisabeth G.
    Robert, Lukian Maxence
    Mukherjee, Tapas
    Prescott, Dave
    Tattoli, Ivan
    Lemire, Paul
    Winer, Daniel A.
    Winer, Shawn
    Streutker, Catherine J.
    Geddes, Kaoru
    Cadwell, Ken
    Ferrero, Richard L.
    Martin, Alberto
    Girardin, Stephen E.
    Philpott, Dana J.
    CELL REPORTS, 2021, 34 (04):